THE SHORT VERSION
- Maintenance may include ongoing treatment, depending on clinical review and access.
- Plan support before a prescription or service ends.
- Agree manageable routines and an early route back to care.
Clarify what maintenance means in your care
Ask whether your current plan is to continue treatment, review it at a set point or prepare to stop. The answer depends on benefit, side effects, health needs and funding arrangements. A lower weight does not by itself tell you whether treatment should end.
For NHS treatment in England, tirzepatide does not have the same fixed maximum treatment period as the NICE weight-management recommendation for injectable semaglutide. Your team should explain the rule that applies to your actual prescription. If you pay privately, include affordability and continuity in the discussion. Do not create an occasional-use or lower-frequency schedule yourself.
Build a plan that survives an ordinary difficult week
Choose routines that do not depend on perfect motivation: a short shopping list, a few meals you can repeat and activity that fits your mobility and timetable. General NHS guidance includes muscle-strengthening activity on at least two days a week. Start at a level that suits you and seek help adapting activity if you have pain, disability or other health concerns.
Think through a likely disruption, such as travel, illness or a demanding week at work. What is the smallest version of your routine that still feels manageable? This is a planning exercise, not a test of discipline. Include rest, enjoyment and social meals in the plan.
Agree what will trigger another conversation
Weight regain after stopping is a recognised possibility. Ask your clinician how to monitor your situation and when to return for review; there is no universal trigger that suits everyone. You may also want to monitor mobility, appetite or a relevant health condition, rather than focusing solely on weight.
If things become harder, bring specific examples: more persistent hunger, difficulty managing meals or a sustained change in weight. Ask about the available support and whether the treatment plan needs reassessment. Keep records of previous medicines and why they stopped. Returning for help is part of ongoing care, and restarting a medicine requires a fresh clinical plan.
Sources you can check
- NHS England: tirzepatide commissioning and treatment review
- NICE: semaglutide weight-management recommendation
- NICE: tirzepatide discussion guide
- NHS: improving strength and flexibility
Editorial presentation updated 24 October 2026. This is general information, not individual medical advice or a claim of independent clinical review. Read the linked source and the leaflet supplied with your medicine for the full context. Suggest a correction.